Therese M Mulvey - Massachusetts General Hospital

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 56 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2–positive Breast Cancer: 5-Year Results and Correlative Analyses from ATEMPT

Paolo Tarantino,Nabihah Tayob,Guillermo Villacampa,Chau Dang,Denise A Yardley,Steven J Isakoff,Vicente Valero,Meredith Faggen,Therese Mulvey,Ron Bose,Douglas Weckstein,Antonio C Wolff,Katherine Reeder-Hayes,Hope S Rugo,Bhuvaneswari Ramaswamy,Dan Zuckerman,Lowell Hart,Vijayakrishna K Gadi,Michael Constantine,Kit Cheng,Audrey Merrill Garrett,P Kelly Marcom,Kathy Albain,Patricia DeFusco,Nadine Tung,Blair Ardman,Rita Nanda,Rachel C Jankowitz,Mothaffar Rimawi,Vandana Abramson,Paula R Pohlmann,Catherine Van Poznak,Andres Forero-Torres,Minetta C Liu,Kathryn J Ruddy,Adrienne G Waks,Michelle DeMeo,Harold J Burstein,Ann H Partridge,Patrizia Dell'Orto,Leila Russo,Emma Krause, Daniel J Newhouse,Busem Binboğa Kurt,Elizabeth A Mittendorf,Bryan Schneider,Aleix Prat,Eric P Winer,Ian E Krop,Sara M Tolaney, Consortium of the TBCRC Translational Investigators, TBCRC Translational Investigators

Journal of Clinical Oncology (2024)

引用0浏览0WOS引用

Physician Disruptive Behavior Compromising Safe Care Delivery

Monika Kumar,Devika Das,Therese M. Mulvey,Navid Sadeghi

JCO ONCOLOGY PRACTICEno. 3 (2024)

引用0浏览0WOS引用

Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards

Robert D. Siegel,Kristine B. LeFebvre,Sarah Temin, Amy Evers,Lisa Barbarotta, Ronda M. Bowman,Alexandre Chan,David W. Dougherty,Michael Ganio,Bradley Hunter, Meredith Klein,Tamara P. Miller,Therese Marie Mulvey, Amanda Ouzts,Martha Polovich,Maritza Salazar-Abshire, Elaine Z. Stenstrup, Christine Marie Sydenstricker,Susan Tsai,MiKaela M. Olsen

ONCOLOGY NURSING FORUMno. 4 (2024): 1-24

引用0浏览0WOS引用

Supportive Care for Cancer Patients Via Telehealth

Tara E. Soumerai,Therese M. Mulvey,Vicki A. Jackson,Inga T. Lennes

Cancer journal (Sudbury, Mass.)（2024）

引用0浏览0WOS引用

Abstract PD18-01: Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I HER2+ Breast Cancer: 5-Year Results and Correlative Analyses from ATEMPT (TBCRC033)

Cancer researchno. 5_Supplement (2023): PD18-01

引用1浏览0引用

Abstract PD17-03: Cell-free DNA Monitoring in a Phase II Study of Adjuvant Endocrine Therapy with CDK 4/6 Inhibitor Ribociclib for Localized HR+/HER2- Breast Cancer (LEADER)

Arielle J. Medford,Lauren Scarpetti,Andrzej Niemierko,Steven J. Isakoff,Beverly Moy,Seth A. Wander, Elizabeth Deluca,Elizabeth Abraham,Jennifer Shin,Lowell Schnipper,Amy E. Comander,Therese Mulvey,Erik Spickard,Ekaterina Kalashnikova,Angel Rodriguez,Leif Ellisen,Aditya Bardia,Laura M. Spring

Cancer Researchno. 5_Supplement (2023): PD17-03

引用0浏览0引用

Cell-free DNA Monitoring in a Phase II Study of Adjuvant Endocrine Therapy with CDK 4/6 Inhibitor Ribociclib for Localized HR+/HER2-breast Cancer (LEADER)

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

Preventing Future Harm: Identifying the Drivers of an Unsafe Discharge to Improve Safety on an Inpatient Oncology Service

Thomas J. Roberts,Jessica Mcguire,Jeffrey W. Clark,Alexis E. Drutchas,Rhaea Photopoulos,Devika Das,Therese M. Mulvey

JCO ONCOLOGY PRACTICEno. 9 (2023): 724-+

引用0浏览0WOS引用

Uncovering the Risks of Anticancer Therapy Through Incident Report Analysis Using a Newly Developed Medical Oncology Incident Taxonomy

Joseph O. Jacobson,Jessica A. Zerillo,James Doolin,Sherri O. Stuver,Anna Revette,Therese Mulvey

Journal of Patient Safety（2023）

引用0浏览0WOS引用

Value, balance, impact: Factors contributing to the exodus of medical oncologists from clinical care

Niharika Dixit,David D. Chism, Breelyn A. Wilky,Corey Speers,Laura Levit,Margaret Kelsey Kirkwood, Jim D. Morgante,Therese M. Mulvey

JCO oncology practiceno. 11_suppl (2023): 52-52

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn